Atlas Trials

Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy

Clinical trial NCT03680261 · UNKNOWN

Trial details

NCT number
NCT03680261
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2018-10-01
Primary completion
2023-09-30
Enrollment
556

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.